Gaudium IVF and Women Health Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Gaudium IVF and Women Health Limited has informed the Exchange about the schedule of a meet to discuss the Q1 FY27 earnings, to be held on August 14, 2026.
28
total announcements
GAUDIUMIVF.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 17 Oct 2026
Market Cap
₹738 Cr
P/E (TTM)
30.0
EPS (TTM)
₹3.38
52W Low
₹69.18
52W High
₹163.18
Dividend Yield
0.00%
Price / Book
4.2
Debt / Equity
16.1
Revenue (TTM)
₹106 Cr
Gross Margin
51.38%
Operating Margin
8.79%
Gaudium IVF and Women Health Limited
Gaudium IVF and Women Health Limited has informed the Exchange about the schedule of a meet to discuss the Q1 FY27 earnings, to be held on August 14, 2026.
Gaudium IVF and Women Health Limited
Gaudium IVF and Women Health Limited, India's first listed IVF company, has launched its first milestone in a planned 19-centre expansion, unveiling its AI-powered Signature Labs in South Delhi. The new centre combines AI-assisted embryology, globally benchmarked laboratory standards, and 17 years of fertility experience to provide high-quality, technology-driven fertility care to aspiring parents.
Gaudium IVF and Women Health Limited
Gaudium IVF and Women Health Limited has informed the Exchange about the commencement of commercial operations at its new IVF Centre/Hub at South Extension, New Delhi, with effect from July 16, 2026.
Gaudium IVF and Women Health Limited
Gaudium IVF and Women Health Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026, stating that the regulation is not applicable to the company as all shares are in demat form and no requests for rematerialisation or dematerialization were received during the quarter.
Gaudium IVF and Women Health Limited
Gaudium IVF and Women Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the announcement of unaudited standalone and consolidated financial results for the quarter ending June 30, 2026.
Gaudium IVF and Women Health Limited
Gaudium IVF and Women Health Limited has submitted a corrigendum to its financial results for the quarter and year ended March 31, 2026, correcting inadvertent regrouping and typographical errors in the comparative figures for the previous financial year ended March 31, 2025.
Gaudium IVF and Women Health Limited
Gaudium IVF and Women Health Limited has informed the Exchange regarding Board Meeting Outcome for Approval For Setting Up Of Gaudium Women Hospital At Lucknow, Uttar Pradesh. The Board of Directors approved the proposal for establishment, development, operation and management of "Gaudium Women Hospital, Lucknow" at the property situated in Lucknow, Uttar Pradesh, through a long-term arrangement with the owner of the said property.
Gaudium IVF and Women Health Limited
Dr. Manika Khanna, a promoter of Gaudium IVF and Women Health Limited, has submitted a disclosure under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing confirms that the Promoter and Promoter Group did not create any encumbrances (pledges) on the company's shares, either directly or indirectly, during the financial year ended March 31, 2026. This annual declaration reassures stakeholders regarding the stability of promoter shareholding.